Clinical Trials Logo

Filter by:
NCT ID: NCT00184548 Terminated - Trauma Clinical Trials

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

CONTROL
Start date: October 2005
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The purpose of the trial is to evaluate that activated recombinant human factor VII (eptacog alfa (activated)) is safe and effective in severely injured trauma patients by assessing mortality and morbidity. Please note that this trial and trial F7TRAUMA-1648 (NCT00323570) have been merged.

NCT ID: NCT00160563 Terminated - Asthma Clinical Trials

Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

Start date: June 2004
Phase: Phase 3
Study type: Interventional

Prolongation of the EPAAC™ trial - NCT00152464 (The Early Prevention of Asthma in Atopic Children). 36 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in young atopic children.

NCT ID: NCT00154427 Terminated - Clinical trials for Acquired Bleeding Disorder

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

Start date: August 2004
Phase: Phase 2
Study type: Interventional

This trial is conducted in Africa, Asia, Europe, South America and the United States of America (USA). The trial is planned to investigate the safety and efficacy of NovoSeven® in the management of post-operative bleeding in patients following cardiac surgery.

NCT ID: NCT00153777 Terminated - HIV Infection Clinical Trials

Cellulose Sulfate and HIV Transmission Among Women

Start date: July 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine the effect of cellulose sulfate on the transmission of HIV to women via vaginal intercourse. The secondary objectives are the effect on the transmission of gonorrhea and chlamydia via the same route. The study hypothesis is that there will be no effect.

NCT ID: NCT00151788 Terminated - Atherosclerosis Clinical Trials

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.

Start date: February 2004
Phase: Phase 2/Phase 3
Study type: Interventional

The effects of pactimibe versus placebo on the progression of atherosclerosis in the carotid arteries will be assessed using standard ultrasound techniques.

NCT ID: NCT00141011 Terminated - Stroke Clinical Trials

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.

NCT ID: NCT00137345 Terminated - Kidney Transplant Clinical Trials

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.

NCT ID: NCT00134628 Terminated - Radiation Injuries Clinical Trials

Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries

Start date: January 2001
Phase: Phase 3
Study type: Interventional

The principle objective of this research is to more precisely determine the degree of benefit that hyperbaric oxygen therapy affords in the treatment of late radiation tissue injury. The study has eight* components. Seven involve the evaluation of established radionecrosis at varying anatomic sites (mandible, larynx, skin, bladder, rectum, colon, and gyn). The eighth will investigate the potential of hyperbaric oxygen (HBO) therapy to prophylax against late radiation tissue injury. *(One of the arms, HORTIS IV - Proctitis has been closed to further patient recruitment. This decision was based on an interim statistical analysis which generated sufficient evidence to support closing down this arm of HORTIS.)

NCT ID: NCT00122525 Terminated - HIV Infections Clinical Trials

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Start date: July 2002
Phase: Phase 3
Study type: Interventional

Observational studies suggest that male circumcision may provide protection against HIV-1 infection. A randomized, controlled, intervention trial was conducted in a general population of South Africa to test this hypothesis.

NCT ID: NCT00080119 Terminated - Tuberculosis Clinical Trials

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Start date: February 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Tuberculosis (TB) is highly endemic in sub-Saharan Africa. The increased burden of TB in settings with high prevalence of the Human Immunodeficiency Virus (HIV) is associated with high rates of transmission of Mycobacterium tuberculosis (M.tb) to both adults and children. Children infected with TB have a higher risk of developing severe disease than adults with TB. The purpose of this study was to determine if the antibiotic isoniazid (INH) prevented TB infection in infants born to HIV-infected mothers.